CNTB
Connect Biopharma Holdings
CNTB
CNTB
20 hedge funds and large institutions have $9.6M invested in Connect Biopharma Holdings in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$38.4K | |
| 2 | +$18.2K | |
| 3 | +$15.3K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$1.79K |
| 5 |
Renaissance Technologies
New York
|
+$522 |
Top Sellers
| 1 | -$792K | |
| 2 | -$581K | |
| 3 | -$261K | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$217K |
| 5 |
Citigroup
New York
|
-$65.5K |